QQ客服 官方微博 反馈留言

	Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial
	Wong, Ka Sing Lawrence; Chen, Christopher; Fu, Jianhui; Chang, Hui Meng; Suwanwela, Nijasri C.; Huang, Yining N.; Han, Zhao; Tan, Kay Sin; Ratanakorn, Disya; Chollate, Pavithra
刊名	LANCET NEUROLOGY
	2010
卷号	9期号:5
ISSN号	1474-4422
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4936723
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wong, Ka Sing Lawrence,Chen, Christopher,Fu, Jianhui,et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial[J]. LANCET NEUROLOGY,2010,9(5).
APA	Wong, Ka Sing Lawrence.,Chen, Christopher.,Fu, Jianhui.,Chang, Hui Meng.,Suwanwela, Nijasri C..,...&Markus, Hugh S..(2010).Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.LANCET NEUROLOGY,9(5).
MLA	Wong, Ka Sing Lawrence,et al."Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial".LANCET NEUROLOGY 9.5(2010).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。